Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease

Patent No. EP1910829 (titled "Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease") was filed by Elan Pharmaceuticals on Jul 19, 2006. The application was issued on Mar 2, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MACLEANDec 2, 2016MILLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1910829

ELAN PHARMACEUTICALS
Application Number
EP06800177A
Filing Date
Jul 19, 2006
Status
Revoked
Dec 10, 2021
Publication Date
Mar 2, 2016